Computational Biologist (Genomics & Variant Interpretation)

About LifecodeLifecode is a direct-to-consumer whole genome sequencing company. We sequence your entire genome and turn it into personal wellness insights you can actually use. We're a small founding team and we're building the data and interpretation engine that makes 3 billion base pairs meaningful to a regular person.The roleYou'll be our first dedicated genomics data hire and own how we go from raw WGS output to interpreted, trustworthy insights. This is a build-from-scratch role: the pipelines, the variant interpretation logic, the evidence standards, and the models we train on our data will largely be your call.What you'll doDesign and own our secondary/tertiary analysis pipeline: alignment, variant calling, QC, annotationBuild the variant interpretation layer — curating evidence from ClinVar, gnomAD, GWAS Catalog, PharmGKB and similar sources into wellness and trait insightsDevelop and validate polygenic risk scores and trait-prediction modelsEvaluate and deploy modern variant effect predictorsWork with our product/engineering lead to ship insights into the customer-facing productWhat we're looking forPhD or MS in computational biology, bioinformatics, human genetics, or a closely related fieldHands-on experience with human genetic data (VCF wrangling, Python interpretation libraries) and inference with SOTA in-silico variant effect prediction models (AlphaGenome, Enformer, SpliceAI, etc.)Strong Python and SQL;Working knowledge of statistical genetics — PRS construction, GWAS interpretation, population stratificationAbility to read a paper, judge the evidence, and decide whether it belongs in a consumer productBias toward shipping. You've worked somewhere small or you want to.Why joinFounders' previous companies have driven over $30M+ in revenue and 5B+ views on social mediaThis is not a traditional, slow-moving life-sciences company, we will taking frontier research and quickly delivering it to the masses Compensation$100K - $130K + competitive equity